Literature DB >> 29278883

MicroRNA-152 inhibits tumor cell growth while inducing apoptosis via the transcriptional repression of cathepsin L in gastrointestinal stromal tumor.

Hong-Jie Lu1,1, Jing Yan2,1, Pei-Ying Jin1,1, Gui-Hong Zheng1, Su-Ming Qin3, Dong-Mei Wu1, Jun Lu1, Yuan-Lin Zheng1.   

Abstract

OBJECTIVE: MicroRNAs are widely thought to play a regulatory role in gene expression. Although the more unique microRNA expression profiles have been reported in several tumors, there remains a scarcity of knowledge in relation to microRNA expression profiles in GISTs. During this study, through the alteration in the expression of microRNA-152 (miR-152) in gastrointestinal stromal tumor (GIST) cells, we subsequently evaluated its ability to influence the processes associated with cancer, including proliferation, migration, invasion, and apoptosis, as well as the associated mechanisms.
METHODS: The expression of miR-152 and cathepsin L (CTSL) in GIST cell lines (GIST882, GIST430, GIST48 and GIST-T1) and normal gastric mucosal cell line RGM-1 were determined. A series of miR-152 mimics, miR-152 inhibitors, and siRNA against CTSL were introduced to treat GIST-T1 cells with the lowest miR-152 and the highest CTSL were assessed. Cell viability, cell cycle entry, apoptosis, and cell migration/invasion were all evaluated by means of CCK-8 assay, flow cytometry analyses of Annexin V-FITC/PI staining, and transwell assays.
RESULTS: The target prediction program and luciferase reporter gene assay verified CTSL is the target of miR-152. Regarding the biological significance of miR-152, siRNA knockdown and ectopic expression studies revealed that miR-152 mimic or siRNA against CTSL exposure reduced cell viability and migration/invasion, which resulted in more cells arrested at the S stage, and induced apoptosis. MiR-152 inhibitor exposure was observed to have induced effects on CTSL cells as opposed to those induced by that of the miR-152 mimics. In contrast, miR-152 downregulation abrogated the effects induced by siRNA against CTSL treatment.
CONCLUSION: The key findings of this study provided evidence suggesting that miR-152 functions by means of binding to CTSL to induce GIST cell apoptosis and inhibit proliferation, migration, and invasion. The anti-tumor role of miR-152 makes it an attractive therapeutic target for GIST.

Entities:  

Keywords:  CTSL; MicroRNA-152; apoptosis; gastrointestinal stromal tumor; invasion; migration; proliferation

Mesh:

Substances:

Year:  2018        PMID: 29278883     DOI: 10.3233/CBM-170809

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  7 in total

1.  'Patchiness' and basic cancer research: unravelling the proteases.

Authors:  Surinder M Soond; Maria V Kozhevnikova; Andrey A Zamyatnin
Journal:  Cell Cycle       Date:  2019-06-24       Impact factor: 4.534

2.  Differential secretome of pancreatic cancer cells in serum-containing conditioned medium reveals CCT8 as a new biomarker of pancreatic cancer invasion and metastasis.

Authors:  Xiaodong Tan; Bing Song; Peng Liu; Lingming Kong; Haoyi Jin; Yunhao Wu
Journal:  Cancer Cell Int       Date:  2019-10-11       Impact factor: 5.722

3.  Cathepsin L promotes secretory IgA response by participating in antigen presentation pathways during Mycoplasma Hyopneumoniae infection.

Authors:  Ning Zhang; Peng Gao; Bao Yin; Jiahe Li; Tong Wu; Yu Kuang; Wenxue Wu; Jinxiang Li
Journal:  PLoS One       Date:  2019-04-15       Impact factor: 3.240

4.  Cathepsin L promotes angiogenesis by regulating the CDP/Cux/VEGF-D pathway in human gastric cancer.

Authors:  Tao Pan; Zhijian Jin; Zhenjia Yu; Xiongyan Wu; Xinyu Chang; Zhiyuan Fan; Fangyuan Li; Xiaofeng Wang; Zhen Li; Quan Zhou; Jianfang Li; Bingya Liu; Liping Su
Journal:  Gastric Cancer       Date:  2020-05-09       Impact factor: 7.370

Review 5.  Overview of microRNAs as liquid biopsy biomarkers for colorectal cancer sub-type profiling and chemoresistance.

Authors:  Alfred Buhagiar; Elisa Seria; Miriana Borg; Joseph Borg; Duncan Ayers
Journal:  Cancer Drug Resist       Date:  2021-10-26

Review 6.  Small Molecules in Rare Tumors: Emerging Role of MicroRNAs in GIST.

Authors:  Juozas Kupcinskas
Journal:  Int J Mol Sci       Date:  2018-01-30       Impact factor: 5.923

Review 7.  Non-Coding RNAs, a Novel Paradigm for the Management of Gastrointestinal Stromal Tumors.

Authors:  Azadeh Amirnasr; Stefan Sleijfer; Erik A C Wiemer
Journal:  Int J Mol Sci       Date:  2020-09-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.